Correlation of Lactate Dehydrogenase Isoenzyme Profile With Outcome in Patients With Advanced Colorectal Cancer Treated With Chemotherapy and Bevacizumab or Cediranib: Retrospective Analysis of the HORIZON I Study

Jair Bar(Tel Aviv University), Glenwood D. Goss(Ontario Institute for Cancer Research), Shethah Morgan(AstraZeneca (United Kingdom)), David Cunningham(Royal Marsden NHS Foundation Trust), Juliane M. Jürgensmeier(AstraZeneca (United Kingdom)), Jane Robertson(Cancer Research UK), Stuart Spencer(AstraZeneca (United Kingdom)), Laura Brooks(University of North Carolina at Chapel Hill)
Clinical Colorectal Cancer
November 13, 2013
10.1016/j.clcc.2013.11.002
Cited by 29

Related Papers

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
|New England Journal of Medicine|2008|2.3k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
|JAMA|2010|1.4k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k